FDA Prepares To Begin Search For Drug Safety Issues At Molecular Level
This article was originally published in The Pink Sheet Daily
Executive Summary
Combination of new science and technology could allow drug developers to identify molecular risk targets, much as they look for therapeutic targets, agency tells advisory panel.